Who Paid My Doc
Mark Latta
Dentist, General Practice Omaha, NE Doctor of Dentistry
NPI 1255601001 CMS profile 399279
2500 California Plz, Omaha, NE 68178
General payments
$101,852
Research payments
$76,077
Ownership & investment interest
$0
Research they led as principal investigator
$48,783
Through program year 2025, Mark Latta of Omaha, NE is reported in the CMS Open Payments database as having received $101,852 across 74 general payments and $76,077 in research payments paid to them. Separately, studies naming them as principal investigator received $48,783 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $12,368 | 11 | |
| 2024 | General | $47,762 | 24 | |
| 2023 | General | $7,947 | 10 | |
| 2022 | General | $31,946 | 18 | |
| 2022 | Research | $13,890 | 1 | |
| 2021 | General | $189 | 2 | |
| 2020 | General | $1,223 | 5 | |
| 2020 | Research | $5,524 | 1 | |
| 2019 | General | $417 | 4 | |
| 2019 | Research | $56,663 | 8 |
Beside peers
- Mark Latta
- Dentist, General Practice median
- Middle half of Dentist, General Practice
- National median
In program year 2025, general payments to Mark Latta were reported at $12,368. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.
Show as a table
| Year | Mark Latta | Dentist, General Practice median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $417 | $61 | $23–$158 | $163 |
| 2020 | $1,223 | $73 | $24–$142 | $114 |
| 2021 | $189 | $75 | $25–$184 | $132 |
| 2022 | $31,946 | $75 | $27–$198 | $149 |
| 2023 | $7,947 | $77 | $28–$200 | $160 |
| 2024 | $47,762 | $74 | $27–$187 | $164 |
| 2025 | $12,368 | $75 | $27–$200 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
84 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, General Practice in Nebraska
Michael Sesemann
Dentist, General Practice · Omaha, NE
Stephanie Vondrak
Dentist, General Practice · Elkhorn, NE
Brian Newell
Dentist, General Practice · Bellevue, NE
Timothy Walker
Dentist, General Practice · Omaha, NE
Christopher Birkestrand
Dentist, General Practice · Minden, NE
Mark Panneton
Dentist, General Practice · Elkhorn, NE
Related records
Dentist, General Practice in Nebraska
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, General Practice
Everyone recorded under this specialty, nationwide.
Doctors in Nebraska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.